Alasdair P. MacGowan
Bristol Centre for Antimicrobial Research and Evaluation
Southmead Health Services NHS Trust and University of Bristol
Bristol
United Kingdom
Name/email consistency: high
- Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model. MacGowan, A.P., Rogers, C.A., Holt, H.A., Bowker, K.E. Antimicrob. Agents Chemother. (2003)
- Mechanism of fluoroquinolone resistance is an important factor in determining the antimicrobial effect of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model. MacGowan, A.P., Bowker, K.E. Antimicrob. Agents Chemother. (2003)
- Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models. MacGowan, A., Bowker, K. Int. J. Antimicrob. Agents (2002)
- Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. MacGowan, A.P., Wise, R. J. Antimicrob. Chemother. (2001)
- In vitro models, in vivo models, and pharmacokinetics: what can we learn from in vitro models?. MacGowan, A., Rogers, C., Bowker, K. Clin. Infect. Dis. (2001)
- Role of pharmacokinetics and pharmacodynamics: does the dose matter?. MacGowan, A.P. Clin. Infect. Dis. (2001)
- Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection. MacGowan, A.P., Rogers, C.A., Holt, H.A., Wootton, M., Bowker, K.E. Antimicrob. Agents Chemother. (2001)
- Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin. MacGowan, A., Rogers, C., Holt, H.A., Wootton, M., Bowker, K. J. Antimicrob. Chemother. (2000)
- The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens. MacGowan, A., Rogers, C., Bowker, K. J. Antimicrob. Chemother. (2000)
- Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infection. MacGowan, A.P., Bowker, K.E., Wootton, M., Holt, H.A. Antimicrob. Agents Chemother. (1999)